Karsten Nysom

Consultant at the Section of paediatric haematology & oncology, Rigshospitalet, Copenhagen since 2005, with a special focus on paediatric CNS tumours.

Chair of the phase 1-2 trial unit of Rigshospitalet since it was established in 2013.

Principal investigator of 22 currently recruiting phase 1-2 trials for children with cancer, including 9 trials for children with CNS tumours.

Chairman of the NOPHO Novel Therapy Working Group

Coordinator of the CNS tumour network under the Danish multidisciplinary working group for children with cancer (DAPHO-CNS)